Jeff Marrazzo, Spark CEO

With Spark safe­ly tucked in­to Roche, its found­ing CEO is off to search for new ad­ven­tures

Spark Ther­a­peu­tics made his­to­ry at the FDA by win­ning the first-ever ap­proval for a gene ther­a­py, when the agency green­light­ed Lux­tur­na in late 2017. But the com­pa­ny and its found­ing CEO are prepar­ing to turn a new leaf.

Jeff Mar­raz­zo, Spark’s chief ex­ec­u­tive since its found­ing in 2013, will step down from his post on April 1, the biotech an­nounced Wednes­day morn­ing. COO Ron Philip was tapped to suc­ceed him af­ter a tran­si­tion pe­ri­od, and told End­points News he had planned to leave the com­pa­ny once its fu­ture with Roche was se­cure.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.